Mens Hair Rejuvenation
with the Revage 670

"My APIRA Revåge 670TM lasers have provided measurable benefits to my patients when used alone or in conjunction with other therapies. 85% benefit, with many experiencing 45% increase in hair counts."
David Melamed, M.D.
New York, NY

A new era of nonsurgical hair restoration technology is here for men with hair loss.

We all know that hair loss can be emotionally devastating for women; hair has long been a symbol of feminine beauty and sensuality. But hair loss in men is no less devastating. Men report reduced self-esteem, difficulty dating and trouble securing a new job. A balding hairline makes a man look and feel older than he is.

Many people with hair loss have dreamed of the “magic bullet,” the special vitamin or treatment that will reverse hair loss. Surgical hair treatments, such as hair transplantation, scalp reduction, flaps and tissue expansion, are available. So is medication, such as Minoxidil and Propecia. However, most treatments have been disappointing, usually saving the hair that’s already there, but doing little to grow back the hair that’s already lost.

For obvious reasons, most people are skeptical of treatments that promise to reverse hair loss. But a new era of hair restoration technology, using “cold” laser hair therapy the Revage 670 offers hope for those who don’t have advanced hair loss. Using the Revage 670 alone and in combination with topical and/or oral medications has produced excellent results for men and women.

Also known as “cold” lasers, the Revage 670 uses therapeutic soft low-light level lasers (LLLL) that were developed in Europe for healing wounds, treating hair loss and other diseases of the scalp.

The Revage 670 uses a pure visible red light at 670 nm, the optimum wavelength and frequency to stimulate a dramatic increase in micro-circulation of blood supplies in the scalp. This increases cellular metabolism and promotes the repair of damaged cells and weakened hair follicles, leading to the cessation of hair loss and the stimulation of hair re-growth.

The exact mechanism of action for visible red LHT at the cellular and sub-cellular level is not clear. However, current evidence suggests the effects are based on enhanced cell proliferation. Specific biological effects can be seen by irradiating a cell (Karu, 1998). In particular, 670 nm light directly affects the physical state of pore molecules.

The physical state of a cell is affected by changing the permeability to calcium ions. An abrupt and transient increase in calcium ion concentrations act as an intracellular messengers. This photochemical change affect the mitochondria, and, in turn, messenger RNA synthesis, which ultimately leads to the observed enhancement of cell proliferation.
 

Karu (1998)1 demonstrated that radiation produces specific biological effects in tissue, while Trelles et al. (1989 and 2006)2,3 Muxeneder (1988)4 and Mester et al. (1985)5 demonstrated the effects of LLLL in multiple trials, including vertebral pain management, the treatment of headaches and local immune responses. Subsequently, LLLL was successfully applied for wound healing. Researchers observed that LLLL stimulated rapid healing in a safe and effective manner, and “many irradiated septic wounds heal as if by first intention.” This same principal is now applied in the Revage 670 in order to repair damaged blood vessels in the scalp by promoting neovascularization, thereby providing hair follicles with the circulation they require.

These clinical studies have led to using LLLL in the form of Laser Hair Therapy. All indicate that the loss of vascularization and gradual loss of hair can be alleviated by irradiating the scalp with 670 nm light.

With the Revage 670 we have the enhanced benefits of low-light level lasers that stimulate biophysical repair and neovascularization. This is a remarkable adjunct to the combination of other therapies we now have. It warrants further consideration and integration into practices serious about treating hair loss.